about
The neurotoxicity of amphetamines during the adolescent periodToxicity of amphetamines: an updateCross-functioning between the extraneuronal monoamine transporter and multidrug resistance protein 1 in the uptake of adrenaline and export of 5-(glutathion-S-yl)adrenaline in rat cardiomyocytesEvaluation of GSH adducts of adrenaline in biological samples.Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes.ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activityNeurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells."Ecstasy" toxicity to adolescent rats following an acute low binge doseSynephrine: from trace concentrations to massive consumption in weight-loss.The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress.Amanita phalloides poisoning: Mechanisms of toxicity and treatment.The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity.Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells.Methylphenidate effects in the young brain: friend or foe?Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways.Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma.The importance of drug metabolites synthesis: the case-study of cardiotoxic anticancer drugs.Biodistribution of polyacrylic acid-coated iron oxide nanoparticles is associated with proinflammatory activation and liver toxicity.Acetaminophen prevents oxidative burst and delays apoptosis in human neutrophils.A breakthrough on Amanita phalloides poisoning: an effective antidotal effect by polymyxin B.The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons.Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes.Development and validation of a GC/IT-MS method for simultaneous quantitation of para and meta-synephrine in biological samples.Adrenaline in pro-oxidant conditions elicits intracellular survival pathways in isolated rat cardiomyocytes.Chemical characterization and protective effect of the Bactris setosa Mart. fruit against oxidative/nitrosative stress.Quantification of alpha-amanitin in biological samples by HPLC using simultaneous UV- diode array and electrochemical detection.Cumulative mitoxantrone-induced haematological and hepatic adverse effects in a subchronic in vivo study.Comprehensive review of cardiovascular toxicity of drugs and related agents.Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures.Quantitative histochemistry for macrophage biodistribution on mice liver and spleen after the administration of a pharmacological-relevant dose of polyacrylic acid-coated iron oxide nanoparticles.Co-ingestion of amatoxins and isoxazoles-containing mushrooms and successful treatment: A case report.The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma.Methylphenidate clinically oral doses improved brain and heart glutathione redox status and evoked renal and cardiac tissue injury in rats.Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study.Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic ImpairmentPixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells
P50
Q21558652-C1A9262C-81BB-494D-8065-DAB48C9B7E26Q22252794-18DC9E0C-1659-4FA3-93BB-CE530FAE837EQ28580011-03656D2C-73EE-4FE7-AEF0-2089BBEBD7C6Q33277360-C8F5E6C4-FCD9-46B1-A3E2-87663A311F4AQ33451343-C42E359E-B2E4-4338-AC32-3C21E60BCFC3Q33492751-69EB6D90-D1B1-4BCB-AF50-7068EF890013Q34314471-04A99424-EBBC-4AD5-BB45-D2E9EE4B425FQ35128510-CB818324-99D8-493A-813E-51046779788FQ36062756-25F29F4B-53C0-4F60-8BA0-8CBBD6C97229Q37809311-258AD6F1-9141-4376-BAC5-132E000B75FCQ38125498-22DA0A1C-9676-46BD-BD2C-284D051D8EC0Q38587818-CC475659-EEC9-4909-A1C8-5E9B04EC4C44Q38622964-7436EB85-4B23-4361-8282-82769CD3E093Q38719848-BF64A9C1-357E-4B60-AF6F-10EEECA53E6EQ38730009-41B1742C-7B88-4671-8C26-24C0B2927EC8Q38987177-884019A2-9AEA-4084-B8BE-B162E2E340CDQ39094453-087A7379-EAFA-4BC1-A788-F0C3D28C6CA9Q39096268-6B042653-C6E1-48DE-A4A9-729362D6DD12Q39231153-16B5D2F3-6536-40BD-82F4-3EC45DC810A5Q39832600-3FAA6D70-5B74-452D-A287-23F1A6CB5A83Q40253741-2599C569-7A63-4494-AD3F-AAD94A3AC43EQ40524324-B37B988A-7109-408E-AE96-A97288DBC1F0Q42702902-B1A553DE-4CDA-49E5-B0D7-6054000E3D8AQ42715803-3E2A9959-7582-41D1-B50D-BEAE2744139FQ42782948-EEF9FF71-12EE-4469-B77B-CBB501D18D24Q43123291-A1143690-FEDB-4013-9F7F-5A29EDF6F43EQ46168826-2663BFB8-2003-45CE-A96A-E1F4D9EBE142Q46458955-E43F9697-5920-4206-AD6C-7D4F019D789CQ46711356-C3F51647-0FFF-499C-8C3B-48F0AFCF960AQ46876309-06FACF2C-E23D-4346-95C6-DE05724D0753Q47556269-11D78AC2-3EE4-4BD2-BF61-35B101861EAAQ48354981-5D24003D-A814-452F-AF6B-F0F70944FF16Q48646139-C9196669-4052-45B3-BF98-9DF1285666C8Q50187007-1CBA9BD5-56F0-407F-81D5-7CD506AFE8B4Q50581913-D5A970C7-30C6-4818-9FCB-865D0C67B319Q51063326-A01E7440-E5A7-4DC9-BF18-4D7DDB45D32EQ52684861-DEABC143-19C6-4E62-9388-CCCA8B2CB4B0Q55654248-01A88A71-49C2-4AAA-ADAD-FBDD760AACF3Q58229934-DDEAB766-30AB-4796-B9D8-9B04ACB37F23Q58798568-CF588D54-D4DF-4ADE-857F-A0F8023B56DC
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Vera Marisa Costa
@ast
Vera Marisa Costa
@en
Vera Marisa Costa
@es
Vera Marisa Costa
@nl
Vera Marisa Costa
@sl
type
label
Vera Marisa Costa
@ast
Vera Marisa Costa
@en
Vera Marisa Costa
@es
Vera Marisa Costa
@nl
Vera Marisa Costa
@sl
altLabel
V M Costa
@en
prefLabel
Vera Marisa Costa
@ast
Vera Marisa Costa
@en
Vera Marisa Costa
@es
Vera Marisa Costa
@nl
Vera Marisa Costa
@sl
P214
P1053
D-6284-2013
P106
P1153
17134373000
P21
P214
P31
P3829
P496
0000-0002-0471-2756
P735
P7859
viaf-306443256